P J Scheuer, J A Summerfield, S Lal, S Sherlock. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAgedAlcoholism/complicationsBiopsyChemical and Drug Induced Liver Injury/complicationsChemical and Drug Induced Liver Injury/diagnosisChemical and Drug Induced Liver Injury/pathologyDrug Therapy, CombinationFemaleHumansIsoniazid/therapeutic useLiver/drug effectsLiver/pathologyLiver Function TestsMaleMiddle AgedPrednisolone/therapeutic useRifampin/administration & dosageRifampin/adverse effectsRifampin/pharmacologyRifampin/therapeutic useStaining and LabelingStreptomycin/therapeutic useTuberculosis, Pulmonary/drug therapy
Substances: See more » PrednisoloneIsoniazidRifampinStreptomycin
Year: 1974 PMID: 4131429 DOI: 10.1016/s0140-6736(74)92381-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321